Company

PhoenixBio

フェニックスバイオ

6190 · TSE · Services

Financials Consolidated

Revenue¥1.57bn+1.6% year on yearConsolidated · FY3/26

Ordinary profit¥131mConsolidated · FY3/26

Net profit¥125mConsolidated · FY3/26

Revenue

¥1.32bnFY3/22

¥2.12bnFY3/23

¥1.72bnFY3/24

¥1.54bnFY3/25

¥1.57bnFY3/26

Ordinary profit

−¥128mFY3/22

¥511mFY3/23

¥43.5mFY3/24

−¥155mFY3/25

¥131mFY3/26

Net profit (attributable)

−¥388mFY3/22

¥493mFY3/23

¥26.4mFY3/24

−¥449mFY3/25

¥125mFY3/26

Op. cash flow

¥16.4mFY3/22

¥277mFY3/23

−¥79.3mFY3/24

−¥73.0mFY3/25

¥68.9mFY3/26

Employees, whole group55 peopleFY3/26

Employees, parent company (non-consolidated)45 peopleFY3/26

Average salary¥5.70mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history

Five-year history
Fiscal year	Revenue	Ordinary profit	Net profit (attributable)	EPS	Total assets	Net assets	Op. cash flow
FY3/26	¥1.57bn+1.6% year on year	¥131.3m	¥125.2m	¥30.81	¥2.19bn	¥1,553m	¥68.9m
FY3/25	¥1.54bn−10.1% year on year	−¥155.2m	−¥448.9m	−¥110.99	¥2.29bn	¥1,365m	−¥73.0m
FY3/24	¥1.72bn−19.2% year on year	¥43.5m	¥26.4m	¥6.98	¥2.72bn	¥1,798m	−¥79.3m
FY3/23	¥2.12bn+60.3% year on year	¥511.3m	¥493.3m	¥145.23	¥3.02bn	¥1,514m	¥277.5m
FY3/22	¥1.32bn	−¥128.0m	−¥388.0m	−¥117.50	¥2.28bn	¥828m	¥16.4m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YKSV · Japan GAAP. Each figure's years come from one report's five-year summary.